Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-03 Sale |
2025-03-04 7:43 pm |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks |
3,263 | $13.03 | $42,520 | 298,429 (Direct) |
View |
| 2025-02-03 Sale |
2025-02-04 8:01 pm |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks |
8,338 | $12.7 | $105,893 | 178,692 (Direct) |
View |
| 2024-05-31 Purchase |
2024-12-03 4:16 pm |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks |
5,657 | $3.2778 | $18,543 | 187,030 (Direct) |
View |
| 2024-11-19 Sale |
2024-11-19 7:52 pm |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks |
1,775 | $9.6847 | $17,190 | 181,373 (Direct) |
View |
| 2024-11-04 Sale |
2024-11-05 4:46 pm |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks |
5,015 | $8.6842 | $43,551 | 178,273 (Direct) |
View |
| 2024-08-02 Sale |
2024-08-05 4:37 pm |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks |
5,220 | $9.0161 | $47,064 | 183,288 (Direct) |
View |
| 2024-05-28 Sale |
2024-05-29 7:38 pm |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark |
1,775 | $9.0074 | $15,988 | 188,508 (Direct) |
View |
| 2024-05-02 Sale |
2024-05-03 4:22 pm |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark |
5,016 | $8.7378 | $43,829 | 185,408 (Direct) |
View |
| 2024-03-04 Sale |
2024-03-06 5:14 pm |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark |
3,760 | $11.12 | $41,816 | 190,424 (Direct) |
View |
| 2023-11-21 Sale |
2023-11-21 5:47 pm |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark |
1,850 | $1.979 | $3,661 | 46,634 (Direct) |
View |
| 2023-05-31 Sale |
2023-06-02 8:31 pm |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark |
1,830 | $7.8023 | $14,278 | 43,609 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-06 6:52 pm |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks |
1,434 | $15.83 | $22,696 | 94,901 (Direct) |
View |
| 2022-11-21 Sale |
2022-11-22 7:06 pm |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark |
1,720 | $18.19 | $31,289 | 19,535 (Direct) |
View |
| 2022-06-02 Sale |
2022-06-02 4:48 pm |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru SVP and General Counsel |
1,795 | $19.73 | $35,419 | 16,380 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-28 Option Award |
2025-03-04 7:43 pm |
N/A 2035-02-28 |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks |
123,000 | $0 | 298,429 (Direct) |
View |
| 2024-11-18 Option Award |
2024-11-19 7:52 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks |
4,875 | $0 | 181,373 (Direct) |
View |
| 2024-05-27 Option Award |
2024-05-29 7:38 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark |
4,875 | $0 | 188,508 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 6:32 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark |
119,550 | $0 | 194,184 (Direct) |
View |
| 2024-01-12 Option Award |
2024-01-17 4:32 pm |
N/A 2034-01-12 |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark |
204,000 | $0 | 250,634 (Direct) |
View |
| 2023-11-18 Option Award |
2023-11-21 5:47 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark |
4,875 | $0 | 46,634 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 8:31 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark |
1,463 | $6.38 | 43,609 (Direct) |
View |
| 2023-05-27 Option Award |
2023-06-02 8:31 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark |
4,875 | $0 | 43,609 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-06 6:52 pm |
N/A 2033-03-02 |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks |
76,800 | $0 | 94,901 (Direct) |
View |
| 2022-11-18 Option Award |
2022-11-22 7:06 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark |
4,875 | $0 | 19,535 (Direct) |
View |
| 2022-05-27 Option Award |
2022-06-02 4:48 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru SVP and General Counsel |
4,875 | $0 | 16,380 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 8:52 pm |
N/A 2032-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru SVP and General Counsel |
48,600 | $0 | 48,600 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:43 pm |
N/A 2032-01-03 |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru SVP and General Counsel |
185,000 | $0 | 185,000 (Direct) |
View |
| 2021-09-04 Tax Withholding |
2021-09-07 5:42 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Matsuda Masaru SVP, General Counsel |
3,412 | $42.22 | 26,932 (Direct) |
View |
| 2021-09-04 Exercise |
2021-09-07 5:42 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Matsuda Masaru SVP, General Counsel |
6,883 | $0 | 26,932 (Direct) |
View |
| 2021-02-15 Option Award |
2021-02-17 5:05 pm |
2022-02-15 2031-02-15 |
HALOZYME THERAPEUTICS INC. | HALO | Matsuda Masaru SVP, General Counsel |
36,855 | $0 | 36,855 (Direct) |
View |
| 2021-02-10 Tax Withholding |
2021-02-12 7:10 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Matsuda Masaru SVP, General Counsel |
3,203 | $50.6 | 43,605 (Direct) |
View |
| 2021-02-12 Tax Withholding |
2021-02-12 7:10 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Matsuda Masaru SVP, General Counsel |
2,047 | $49.84 | 43,605 (Direct) |
View |
| 2021-02-10 Exercise |
2021-02-12 7:10 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Matsuda Masaru SVP, General Counsel |
10,386 | $0 | 43,605 (Direct) |
View |
| 2020-09-04 Tax Withholding |
2020-09-04 6:13 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Matsuda Masaru SVP, General Counsel |
2,380 | $27.7 | 25,208 (Direct) |
View |
| 2020-09-04 Exercise |
2020-09-04 6:13 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Matsuda Masaru SVP, General Counsel |
6,884 | $0 | 25,208 (Direct) |
View |